CODEL (Alliance-N0577; EORTC-26081/22086; NRG-1071; NCIC-CEC-2): Phase III Randomized Study of RT vs. RT+TMZ vs. TMZ for Newly Diagnosed 1p/19q-Codeleted Anaplastic Oligodendroglial Tumors. Analysis of Patients Treated on the Original Protocol Design (PL02.005)
Year: 2016
Type: article
Source: Neurology
Authors: Kurt Jaeckle, Michael Vogelbaum, Karla Ballman, S. Keith Anderson, Caterina Giannini, Kenneth Aldape, Jane Cerhan, Jeffrey S Wefel, Donald Nordstrom, Robert Jenkins, Martin Klein, Jeffrey Raizer, Martin Van Den Bent, Wolfgang Wick, Patrick Flynn, Frederick Dhermain, J Cairncross, Evanthia Galanis, Paul Brown
Institutions: Mayo Clinic in Florida, Cleveland Clinic Lerner College of Medicine, Weill Cornell Medicine, Mayo Clinic, Toronto General Hospital, Princess Margaret Cancer Centre, The University of Texas MD Anderson Cancer Center, Amsterdam UMC Location Vrije Universiteit Amsterdam, Northwestern University, Erasmus MC, Heidelberg University, Park Nicollet Clinic, Institut Gustave Roussy, University of Calgary, Mayo Clinic Comprehensive Cancer Center (Minnesota)
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2463189776